Methylphenidate and Pancreatic Enzyme Replacement Therapy: Import Duties
Commons · Question 46602 · Tabled 17 Apr 2025 · Department of Health and Social Care · Official record
Answered 29 Apr 2025
Question
Asked by Jess Brown-Fuller
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of US tariffs on the domestic supply of (a) methylphenidate and (b) pancreatic enzyme replacement therapy.
Answer
Answered by Karin Smyth, 29 Apr 2025
The Department is working closely with life sciences stakeholders and other Government departments to assess the potential impact of United States tariffs on global medicine supply chains. We have a range of well-established processes to mitigate risks to...